Advertisement

Introduction

  • Takayuki Kinoshita
Chapter

Abstract

In the surgical treatment of breast cancer, conservative treatment and sentinel lymph node biopsy have already become the standard of care. In addition to being less invasive, treatments are expected to have good aesthetic outcomes. In Japan, the incidence of breast cancer (Fig. 1.1) and the detection rate for early-stage disease have increased due to widespread use of mammography and advances in diagnostic imaging, as is the case in other developed countries. Given this historical background, nonsurgical ablative therapies, noninvasive surgical therapies, have started to attract attention due to patient demand. The nonsurgical ablative therapies used in clinical practice for breast cancer are cryoablation, high-intensity focused ultrasound (HIFU), and radiofrequency ablation (RFA). In Japan, RFA became widespread quickly because of the prevalence and convenience of the device. In this book, an outline of the research on RFA funded by the Japan Agency for Medical Research and Development (AMED), prospects for RFA, and the current status of cryoablation and HIFU are discussed.

Keywords

Breast Cancer Sentinel Lymph Node Biopsy Breast Conservation Surgery Japanese Breast Cancer Society Multicentre Clinical Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Jeffrey SS, et al. Radiofrequency ablation of breast cancer. Arch Surg. 1999;134:1064–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Izzo F, et al. Radiofrequency ablation in patients with primary breast carcinoma. Cancer. 2001;92:2036–44.CrossRefPubMedGoogle Scholar
  3. 3.
    Burak WE, et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical resection. Cancer. 2003;98:1369–76.CrossRefPubMedGoogle Scholar
  4. 4.
    Singletary SE, et al. Radiofrequency ablation for primary breast cancer. Breast Cancer. 2003;10:4–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Hayashi AH, et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg. 2003;185:429–35.CrossRefPubMedGoogle Scholar
  6. 6.
    Fornage BD, et al. Small breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology. 2004;231:215–24.CrossRefPubMedGoogle Scholar
  7. 7.
    Noguchi M, et al. Radiofrequency ablation of small breast cancer followed by surgical resection. J Surg Oncol. 2006;93:120–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Khatri VP, et al. A phase II trial ogf image-guided radiofrequency ablation of small invasive breast carcinoma: use of saline-cooled tip electrode. Ann Surg Oncol. 2007;14:1644–52.CrossRefPubMedGoogle Scholar
  9. 9.
    Medina-Franco H, et al. Radiofrequency ablation of invasive breast carcinoma: a phase II trial. Ann Surg Oncol. 2008;15:1689–95.CrossRefPubMedGoogle Scholar
  10. 10.
    Garbay JR, et al. Radiofrequency thermal ablation of breast cancer local recurrence: a phase II clinical trial. Ann Surg Oncol. 2008;15:3222–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Imoto S, et al. Feasibility study on radiofrequency ablation followed by partial mastectomy for stage I breast cancer patients. Breast. 2009;18:130–4.CrossRefPubMedGoogle Scholar
  12. 12.
    Kinoshita T, et al. Radiofrequency ablation as local therapy for early breast carcinomas. Breast Cancer. 2011;18:10–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Ohtani S, et al. Radiofrequency ablation of early breast cancer followed by delayed surgical resection. – A promising alternative to breast-conserving therapy. Breast. 2011;20(5):431–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Pfleiderer SO, Freesmeyer MG, Marx C, et al. Cryotherapy of breast cancer under ultrasound guidance: initial results and limitations. Eur Radiol. 2002;12:3009–14.PubMedGoogle Scholar
  15. 15.
    Sabel MS, Kaufman CS, Whitworth P, et al. Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial. Ann Surg Oncol. 2004;11:542–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Pfleiderer SO, Marx C, Camara O, et al. Ultrasound-guided, percutaneous cryotherapy of small (<15mm) breast cancers. Invest Radiol. 2005;40(7):472–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Niu LZ, Xu KC, He WB, et al. Efficacy of percutaneous cryoablation for small solitary breast cancer in termpathologic evidence. Technol Cancer Res Treat. 2007;6:460–1.Google Scholar
  18. 18.
    Morin J, Traore’ A, Dionne G, et al. Magnetic resonance-guided percutaneous cryosurgery of breast carcinoma: technique and early clinical results. Can J Surg. 2007;47:347–51.Google Scholar
  19. 19.
    Pusztaszeri M, Vlastos G, Kinkel K, et al. Histopathological study of breast cancer and normal breast tissue after magnetic resonance-guided cryotherapy ablation. Cryobiology. 2007;55(1):44–51.CrossRefPubMedGoogle Scholar
  20. 20.
    Manenti G, Perretta T, Gaspari E, et al. Percutaneous local ablation of unifocal subclinical breast cancer: clinical experience and preliminary results of cryotherapy. Eur Radiol. 2011;21:2344–53.CrossRefPubMedGoogle Scholar
  21. 21.
    Gianfelice D, Khiat A, Amara M, et al. MRI imaging-guided focused ultrasound surgery of breast cancer: correlation of dynamic contrast-enhanced MRI with histopathologic findings. Breast Cancer Res Treat. 2003;12:32–8.Google Scholar
  22. 22.
    Wu F, Wang ZB, Cao YD, et al. A randomized clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localized breast cancer. Br J Cancer. 2003;89:2227–33.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Zippel DB, Papa MZ. The use of MR imaging guided focused ultrasound in breast cancer patients; a preliminary phase one study and review. Breast Cancer. 2005;12:32–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Furusawa H, Namba K, Thomsen S, et al. Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. J Am Coll Surg. 2006;203:54–63.CrossRefPubMedGoogle Scholar
  25. 25.
    Khiat A, Gianfelice D, Amara M, et al. Influence of post-treatment delay on the evaluation of the response to focused ultrasound surgery by breast cancer by dynamic contrast enhanced MRI. Br J Radiol. 2006;79:308–14.CrossRefPubMedGoogle Scholar
  26. 26.
    Gianfelice D, Khiat A, Boulanger Y, et al. Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjuvant to tamoxifen therapy in high-risk surgical patients with breast carcinoma. J Vasc Interv Radiol. 2003;14:1275–82.CrossRefPubMedGoogle Scholar
  27. 27.
    Wu F, Wang ZB, Zhu H, et al. Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res Treat. 2005;92:51–60.CrossRefPubMedGoogle Scholar
  28. 28.
    Oura S, Tamaki T, Hirai I, et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer. 2007;14:48–54.CrossRefPubMedGoogle Scholar
  29. 29.
    Furusawa H, Namba K, Nakahara H, et al. The evolving non-surgical ablation of breast cancer: MR guided focused ultrasound (MRgFUS). Breast Cancer. 2007;14:55–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Littrup PJ, Jallad B, Chandiwala-Mody P, et al. Cryotherapy for breast cancer: a feasibility study without excision. J Vasc Interv Radiol. 2009;20:1329–41.CrossRefPubMedGoogle Scholar
  31. 31.
    Yamamoto N, Fujimoto H, Nakamura R, et al. Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer. Breast Cancer. 2011;18:3–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Fukuma E, Nakashima H, Tozaki M. Nonsurgical cryoablation for small breast cancer (oral presentation). In: American Society of Breast Surgeons 13th Annual Meeting, Edition. Phoenix, April 27–May 1;2012.Google Scholar

Copyright information

© Springer Japan 2016

Authors and Affiliations

  1. 1.Division of Breast SurgeryNational Cancer Center HospitalTokyoJapan

Personalised recommendations